nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—P2RY12—epithelium—ovarian cancer	0.018	0.123	CbGeAlD
Treprostinil—PPARD—uterine cervix—ovarian cancer	0.0148	0.102	CbGeAlD
Treprostinil—PPARD—decidua—ovarian cancer	0.0141	0.0968	CbGeAlD
Treprostinil—PTGIR—epithelium—ovarian cancer	0.0115	0.0787	CbGeAlD
Treprostinil—PPARD—female reproductive system—ovarian cancer	0.0111	0.0761	CbGeAlD
Treprostinil—PPARD—female gonad—ovarian cancer	0.0101	0.0693	CbGeAlD
Treprostinil—PPARD—vagina—ovarian cancer	0.0101	0.0689	CbGeAlD
Treprostinil—PTGIR—gonad—ovarian cancer	0.00956	0.0655	CbGeAlD
Treprostinil—PPARD—testis—ovarian cancer	0.00897	0.0614	CbGeAlD
Treprostinil—PTGIR—female reproductive system—ovarian cancer	0.00853	0.0585	CbGeAlD
Treprostinil—PTGIR—female gonad—ovarian cancer	0.00777	0.0532	CbGeAlD
Treprostinil—PTGIR—testis—ovarian cancer	0.00689	0.0472	CbGeAlD
Treprostinil—PPARD—lymph node—ovarian cancer	0.0065	0.0445	CbGeAlD
Treprostinil—PTGIR—lymph node—ovarian cancer	0.00499	0.0342	CbGeAlD
Treprostinil—CYP2C9—female reproductive system—ovarian cancer	0.00305	0.0209	CbGeAlD
Treprostinil—Asthenia—Topotecan—ovarian cancer	0.00128	0.00194	CcSEcCtD
Treprostinil—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00128	0.00193	CcSEcCtD
Treprostinil—Vomiting—Chlorambucil—ovarian cancer	0.00128	0.00193	CcSEcCtD
Treprostinil—Pruritus—Topotecan—ovarian cancer	0.00126	0.00191	CcSEcCtD
Treprostinil—Erythema—Paclitaxel—ovarian cancer	0.00126	0.00191	CcSEcCtD
Treprostinil—Feeling abnormal—Vinorelbine—ovarian cancer	0.00126	0.00191	CcSEcCtD
Treprostinil—Asthenia—Melphalan—ovarian cancer	0.00125	0.0019	CcSEcCtD
Treprostinil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00125	0.00189	CcSEcCtD
Treprostinil—Pruritus—Melphalan—ovarian cancer	0.00124	0.00187	CcSEcCtD
Treprostinil—Tension—Paclitaxel—ovarian cancer	0.00124	0.00187	CcSEcCtD
Treprostinil—Haemoglobin—Docetaxel—ovarian cancer	0.00123	0.00187	CcSEcCtD
Treprostinil—Rhinitis—Docetaxel—ovarian cancer	0.00123	0.00186	CcSEcCtD
Treprostinil—Haemorrhage—Docetaxel—ovarian cancer	0.00123	0.00186	CcSEcCtD
Treprostinil—Cardiac failure—Epirubicin—ovarian cancer	0.00123	0.00185	CcSEcCtD
Treprostinil—Nervousness—Paclitaxel—ovarian cancer	0.00122	0.00185	CcSEcCtD
Treprostinil—Diarrhoea—Topotecan—ovarian cancer	0.00122	0.00185	CcSEcCtD
Treprostinil—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00122	0.00185	CcSEcCtD
Treprostinil—Back pain—Paclitaxel—ovarian cancer	0.00122	0.00184	CcSEcCtD
Treprostinil—Pharyngitis—Docetaxel—ovarian cancer	0.00122	0.00184	CcSEcCtD
Treprostinil—Muscle spasms—Paclitaxel—ovarian cancer	0.00121	0.00183	CcSEcCtD
Treprostinil—Abdominal pain—Vinorelbine—ovarian cancer	0.00121	0.00183	CcSEcCtD
Treprostinil—Body temperature increased—Vinorelbine—ovarian cancer	0.00121	0.00183	CcSEcCtD
Treprostinil—Oedema peripheral—Docetaxel—ovarian cancer	0.00121	0.00183	CcSEcCtD
Treprostinil—Diarrhoea—Melphalan—ovarian cancer	0.0012	0.00181	CcSEcCtD
Treprostinil—Pain in extremity—Epirubicin—ovarian cancer	0.0012	0.00181	CcSEcCtD
Treprostinil—Nausea—Chlorambucil—ovarian cancer	0.00119	0.0018	CcSEcCtD
Treprostinil—Dizziness—Topotecan—ovarian cancer	0.00118	0.00179	CcSEcCtD
Treprostinil—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00117	0.00177	CcSEcCtD
Treprostinil—Anaemia—Paclitaxel—ovarian cancer	0.00116	0.00176	CcSEcCtD
Treprostinil—Angioedema—Paclitaxel—ovarian cancer	0.00115	0.00174	CcSEcCtD
Treprostinil—Flushing—Docetaxel—ovarian cancer	0.00114	0.00172	CcSEcCtD
Treprostinil—Vomiting—Topotecan—ovarian cancer	0.00114	0.00172	CcSEcCtD
Treprostinil—Malaise—Paclitaxel—ovarian cancer	0.00114	0.00172	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—ovarian cancer	0.00113	0.00172	CcSEcCtD
Treprostinil—Syncope—Paclitaxel—ovarian cancer	0.00113	0.00171	CcSEcCtD
Treprostinil—Rash—Topotecan—ovarian cancer	0.00113	0.0017	CcSEcCtD
Treprostinil—Dermatitis—Topotecan—ovarian cancer	0.00113	0.0017	CcSEcCtD
Treprostinil—Headache—Topotecan—ovarian cancer	0.00112	0.00169	CcSEcCtD
Treprostinil—Palpitations—Paclitaxel—ovarian cancer	0.00111	0.00168	CcSEcCtD
Treprostinil—Vomiting—Melphalan—ovarian cancer	0.00111	0.00168	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—ovarian cancer	0.00111	0.00168	CcSEcCtD
Treprostinil—Loss of consciousness—Paclitaxel—ovarian cancer	0.00111	0.00168	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—ovarian cancer	0.00111	0.00167	CcSEcCtD
Treprostinil—Rash—Melphalan—ovarian cancer	0.0011	0.00167	CcSEcCtD
Treprostinil—Dermatitis—Melphalan—ovarian cancer	0.0011	0.00167	CcSEcCtD
Treprostinil—Cough—Paclitaxel—ovarian cancer	0.0011	0.00166	CcSEcCtD
Treprostinil—Asthenia—Vinorelbine—ovarian cancer	0.0011	0.00166	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—ovarian cancer	0.00109	0.00165	CcSEcCtD
Treprostinil—Pruritus—Vinorelbine—ovarian cancer	0.00108	0.00164	CcSEcCtD
Treprostinil—Myalgia—Paclitaxel—ovarian cancer	0.00107	0.00162	CcSEcCtD
Treprostinil—Chest pain—Paclitaxel—ovarian cancer	0.00107	0.00162	CcSEcCtD
Treprostinil—Arthralgia—Paclitaxel—ovarian cancer	0.00107	0.00162	CcSEcCtD
Treprostinil—Anxiety—Paclitaxel—ovarian cancer	0.00107	0.00162	CcSEcCtD
Treprostinil—Erythema—Docetaxel—ovarian cancer	0.00107	0.00162	CcSEcCtD
Treprostinil—Nausea—Topotecan—ovarian cancer	0.00106	0.00161	CcSEcCtD
Treprostinil—Discomfort—Paclitaxel—ovarian cancer	0.00106	0.0016	CcSEcCtD
Treprostinil—Diarrhoea—Vinorelbine—ovarian cancer	0.00105	0.00158	CcSEcCtD
Treprostinil—Nausea—Melphalan—ovarian cancer	0.00104	0.00157	CcSEcCtD
Treprostinil—Influenza—Epirubicin—ovarian cancer	0.00103	0.00156	CcSEcCtD
Treprostinil—Back pain—Docetaxel—ovarian cancer	0.00103	0.00156	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—ovarian cancer	0.00103	0.00156	CcSEcCtD
Treprostinil—Oedema—Paclitaxel—ovarian cancer	0.00103	0.00156	CcSEcCtD
Treprostinil—Muscle spasms—Docetaxel—ovarian cancer	0.00103	0.00155	CcSEcCtD
Treprostinil—Infection—Paclitaxel—ovarian cancer	0.00102	0.00155	CcSEcCtD
Treprostinil—Shock—Paclitaxel—ovarian cancer	0.00101	0.00153	CcSEcCtD
Treprostinil—Dizziness—Vinorelbine—ovarian cancer	0.00101	0.00153	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—ovarian cancer	0.00101	0.00152	CcSEcCtD
Treprostinil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00101	0.00152	CcSEcCtD
Treprostinil—Tachycardia—Paclitaxel—ovarian cancer	0.001	0.00152	CcSEcCtD
Treprostinil—Bronchitis—Epirubicin—ovarian cancer	0.000994	0.0015	CcSEcCtD
Treprostinil—Anaemia—Docetaxel—ovarian cancer	0.000987	0.00149	CcSEcCtD
Treprostinil—Anorexia—Paclitaxel—ovarian cancer	0.00098	0.00148	CcSEcCtD
Treprostinil—Vomiting—Vinorelbine—ovarian cancer	0.000972	0.00147	CcSEcCtD
Treprostinil—Rash—Vinorelbine—ovarian cancer	0.000963	0.00146	CcSEcCtD
Treprostinil—Dermatitis—Vinorelbine—ovarian cancer	0.000963	0.00146	CcSEcCtD
Treprostinil—Hypotension—Paclitaxel—ovarian cancer	0.00096	0.00145	CcSEcCtD
Treprostinil—Headache—Vinorelbine—ovarian cancer	0.000957	0.00145	CcSEcCtD
Treprostinil—Syncope—Docetaxel—ovarian cancer	0.000957	0.00145	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—ovarian cancer	0.000956	0.00145	CcSEcCtD
Treprostinil—Palpitations—Docetaxel—ovarian cancer	0.000943	0.00143	CcSEcCtD
Treprostinil—Loss of consciousness—Docetaxel—ovarian cancer	0.000938	0.00142	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000936	0.00142	CcSEcCtD
Treprostinil—Cough—Docetaxel—ovarian cancer	0.000931	0.00141	CcSEcCtD
Treprostinil—Insomnia—Paclitaxel—ovarian cancer	0.00093	0.00141	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—ovarian cancer	0.000927	0.0014	CcSEcCtD
Treprostinil—Paraesthesia—Paclitaxel—ovarian cancer	0.000923	0.0014	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—ovarian cancer	0.000919	0.00139	CcSEcCtD
Treprostinil—Dyspnoea—Paclitaxel—ovarian cancer	0.000916	0.00139	CcSEcCtD
Treprostinil—Arthralgia—Docetaxel—ovarian cancer	0.000909	0.00138	CcSEcCtD
Treprostinil—Myalgia—Docetaxel—ovarian cancer	0.000909	0.00138	CcSEcCtD
Treprostinil—Chest pain—Docetaxel—ovarian cancer	0.000909	0.00138	CcSEcCtD
Treprostinil—Nausea—Vinorelbine—ovarian cancer	0.000908	0.00137	CcSEcCtD
Treprostinil—Dyspepsia—Paclitaxel—ovarian cancer	0.000905	0.00137	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—ovarian cancer	0.000896	0.00136	CcSEcCtD
Treprostinil—Decreased appetite—Paclitaxel—ovarian cancer	0.000893	0.00135	CcSEcCtD
Treprostinil—Fatigue—Paclitaxel—ovarian cancer	0.000886	0.00134	CcSEcCtD
Treprostinil—Pain—Paclitaxel—ovarian cancer	0.000879	0.00133	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—ovarian cancer	0.000878	0.00133	CcSEcCtD
Treprostinil—Oedema—Docetaxel—ovarian cancer	0.000871	0.00132	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—ovarian cancer	0.000869	0.00132	CcSEcCtD
Treprostinil—Infection—Docetaxel—ovarian cancer	0.000865	0.00131	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—ovarian cancer	0.000864	0.00131	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—ovarian cancer	0.000857	0.0013	CcSEcCtD
Treprostinil—Shock—Docetaxel—ovarian cancer	0.000857	0.0013	CcSEcCtD
Treprostinil—Thrombocytopenia—Docetaxel—ovarian cancer	0.000853	0.00129	CcSEcCtD
Treprostinil—Tachycardia—Docetaxel—ovarian cancer	0.00085	0.00129	CcSEcCtD
Treprostinil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000847	0.00128	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—ovarian cancer	0.000842	0.00127	CcSEcCtD
Treprostinil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00084	0.00127	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—ovarian cancer	0.000831	0.00126	CcSEcCtD
Treprostinil—Anorexia—Docetaxel—ovarian cancer	0.00083	0.00126	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—ovarian cancer	0.000829	0.00125	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—ovarian cancer	0.000829	0.00125	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—ovarian cancer	0.000827	0.00125	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—ovarian cancer	0.000821	0.00124	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—ovarian cancer	0.000815	0.00123	CcSEcCtD
Treprostinil—Hypotension—Docetaxel—ovarian cancer	0.000814	0.00123	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—ovarian cancer	0.000813	0.00123	CcSEcCtD
Treprostinil—Abdominal pain—Paclitaxel—ovarian cancer	0.000812	0.00123	CcSEcCtD
Treprostinil—Body temperature increased—Paclitaxel—ovarian cancer	0.000812	0.00123	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—ovarian cancer	0.000804	0.00122	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—ovarian cancer	0.0008	0.00121	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000794	0.0012	CcSEcCtD
Treprostinil—Insomnia—Docetaxel—ovarian cancer	0.000788	0.00119	CcSEcCtD
Treprostinil—Paraesthesia—Docetaxel—ovarian cancer	0.000782	0.00118	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—ovarian cancer	0.000779	0.00118	CcSEcCtD
Treprostinil—Dyspnoea—Docetaxel—ovarian cancer	0.000777	0.00118	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—ovarian cancer	0.000769	0.00116	CcSEcCtD
Treprostinil—Flushing—Epirubicin—ovarian cancer	0.000768	0.00116	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—ovarian cancer	0.000767	0.00116	CcSEcCtD
Treprostinil—Dyspepsia—Docetaxel—ovarian cancer	0.000767	0.00116	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—ovarian cancer	0.000765	0.00116	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—ovarian cancer	0.00076	0.00115	CcSEcCtD
Treprostinil—Decreased appetite—Docetaxel—ovarian cancer	0.000757	0.00115	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—ovarian cancer	0.000754	0.00114	CcSEcCtD
Treprostinil—Fatigue—Docetaxel—ovarian cancer	0.000751	0.00114	CcSEcCtD
Treprostinil—Pain—Docetaxel—ovarian cancer	0.000745	0.00113	CcSEcCtD
Treprostinil—Asthenia—Paclitaxel—ovarian cancer	0.000737	0.00112	CcSEcCtD
Treprostinil—Pruritus—Paclitaxel—ovarian cancer	0.000727	0.0011	CcSEcCtD
Treprostinil—Erythema—Epirubicin—ovarian cancer	0.00072	0.00109	CcSEcCtD
Treprostinil—Feeling abnormal—Docetaxel—ovarian cancer	0.000718	0.00109	CcSEcCtD
Treprostinil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000712	0.00108	CcSEcCtD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00071	0.00367	CbGpPWpGaD
Treprostinil—Flushing—Doxorubicin—ovarian cancer	0.00071	0.00107	CcSEcCtD
Treprostinil—Tension—Epirubicin—ovarian cancer	0.000707	0.00107	CcSEcCtD
Treprostinil—Diarrhoea—Paclitaxel—ovarian cancer	0.000703	0.00106	CcSEcCtD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000701	0.00363	CbGpPWpGaD
Treprostinil—Nervousness—Epirubicin—ovarian cancer	0.000699	0.00106	CcSEcCtD
Treprostinil—Back pain—Epirubicin—ovarian cancer	0.000696	0.00105	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—ovarian cancer	0.000692	0.00105	CcSEcCtD
Treprostinil—Abdominal pain—Docetaxel—ovarian cancer	0.000689	0.00104	CcSEcCtD
Treprostinil—Body temperature increased—Docetaxel—ovarian cancer	0.000689	0.00104	CcSEcCtD
Treprostinil—Dizziness—Paclitaxel—ovarian cancer	0.00068	0.00103	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—STAT3—ovarian cancer	0.000669	0.00346	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Epirubicin—ovarian cancer	0.000668	0.00101	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—ovarian cancer	0.000666	0.00101	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—ovarian cancer	0.000665	0.00101	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—DLC1—ovarian cancer	0.000657	0.0034	CbGpPWpGaD
Treprostinil—Tension—Doxorubicin—ovarian cancer	0.000654	0.000989	CcSEcCtD
Treprostinil—Vomiting—Paclitaxel—ovarian cancer	0.000653	0.000989	CcSEcCtD
Treprostinil—Malaise—Epirubicin—ovarian cancer	0.000649	0.000983	CcSEcCtD
Treprostinil—Rash—Paclitaxel—ovarian cancer	0.000648	0.000981	CcSEcCtD
Treprostinil—Dermatitis—Paclitaxel—ovarian cancer	0.000647	0.00098	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—ovarian cancer	0.000647	0.000979	CcSEcCtD
Treprostinil—Syncope—Epirubicin—ovarian cancer	0.000646	0.000977	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—ovarian cancer	0.000644	0.000975	CcSEcCtD
Treprostinil—Headache—Paclitaxel—ovarian cancer	0.000644	0.000975	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000643	0.00333	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000641	0.00332	CbGpPWpGaD
Treprostinil—Muscle spasms—Doxorubicin—ovarian cancer	0.00064	0.000969	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—ovarian cancer	0.000636	0.000963	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—ovarian cancer	0.000633	0.000958	CcSEcCtD
Treprostinil—Cough—Epirubicin—ovarian cancer	0.000628	0.000951	CcSEcCtD
Treprostinil—Asthenia—Docetaxel—ovarian cancer	0.000625	0.000946	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—ovarian cancer	0.00062	0.00321	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000618	0.000936	CcSEcCtD
Treprostinil—Pruritus—Docetaxel—ovarian cancer	0.000616	0.000933	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—ovarian cancer	0.000616	0.000932	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—ovarian cancer	0.000613	0.000928	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—ovarian cancer	0.000613	0.000928	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—ovarian cancer	0.000613	0.000928	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—ovarian cancer	0.000611	0.000925	CcSEcCtD
Treprostinil—Nausea—Paclitaxel—ovarian cancer	0.00061	0.000924	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—ovarian cancer	0.000606	0.000917	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—ovarian cancer	0.000601	0.000909	CcSEcCtD
Treprostinil—PPARD—Metabolism—CYTB—ovarian cancer	0.000598	0.00309	CbGpPWpGaD
Treprostinil—Syncope—Doxorubicin—ovarian cancer	0.000597	0.000904	CcSEcCtD
Treprostinil—Diarrhoea—Docetaxel—ovarian cancer	0.000596	0.000902	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—ovarian cancer	0.000593	0.00307	CbGpPWpGaD
Treprostinil—Palpitations—Doxorubicin—ovarian cancer	0.000589	0.000891	CcSEcCtD
Treprostinil—Oedema—Epirubicin—ovarian cancer	0.000588	0.000889	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000586	0.000886	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000584	0.00302	CbGpPWpGaD
Treprostinil—Infection—Epirubicin—ovarian cancer	0.000584	0.000884	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—BCL9—ovarian cancer	0.000582	0.00301	CbGpPWpGaD
Treprostinil—Cough—Doxorubicin—ovarian cancer	0.000581	0.00088	CcSEcCtD
Treprostinil—Shock—Epirubicin—ovarian cancer	0.000578	0.000875	CcSEcCtD
Treprostinil—Dizziness—Docetaxel—ovarian cancer	0.000576	0.000872	CcSEcCtD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000576	0.00298	CbGpPWpGaD
Treprostinil—Thrombocytopenia—Epirubicin—ovarian cancer	0.000575	0.000871	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—ovarian cancer	0.000573	0.000868	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—ovarian cancer	0.000567	0.000858	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—ovarian cancer	0.000567	0.000858	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—ovarian cancer	0.000567	0.000858	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—SOD1—ovarian cancer	0.000566	0.00293	CbGpPWpGaD
Treprostinil—Anxiety—Doxorubicin—ovarian cancer	0.000565	0.000855	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—PPP2R1A—ovarian cancer	0.000563	0.00291	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.00056	0.0029	CbGpPWpGaD
Treprostinil—Discomfort—Doxorubicin—ovarian cancer	0.00056	0.000848	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—ovarian cancer	0.00056	0.000848	CcSEcCtD
Treprostinil—Vomiting—Docetaxel—ovarian cancer	0.000554	0.000838	CcSEcCtD
Treprostinil—Rash—Docetaxel—ovarian cancer	0.000549	0.000831	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—ovarian cancer	0.000549	0.000831	CcSEcCtD
Treprostinil—Dermatitis—Docetaxel—ovarian cancer	0.000549	0.000831	CcSEcCtD
Treprostinil—Headache—Docetaxel—ovarian cancer	0.000546	0.000826	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—ovarian cancer	0.000544	0.000823	CcSEcCtD
Treprostinil—Infection—Doxorubicin—ovarian cancer	0.00054	0.000818	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000535	0.00081	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—BCL9—ovarian cancer	0.000535	0.00277	CbGpPWpGaD
Treprostinil—Shock—Doxorubicin—ovarian cancer	0.000535	0.00081	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000532	0.000806	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—ovarian cancer	0.000531	0.000804	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—ovarian cancer	0.000531	0.000803	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—ovarian cancer	0.000528	0.000799	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—ovarian cancer	0.000524	0.000793	CcSEcCtD
Treprostinil—PPARD—Metabolism—PPP1CC—ovarian cancer	0.000522	0.0027	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BRIP1—ovarian cancer	0.000522	0.0027	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SOD1—ovarian cancer	0.000521	0.00269	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PPP2R1A—ovarian cancer	0.000518	0.00268	CbGpPWpGaD
Treprostinil—Anorexia—Doxorubicin—ovarian cancer	0.000518	0.000784	CcSEcCtD
Treprostinil—Nausea—Docetaxel—ovarian cancer	0.000517	0.000783	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—ovarian cancer	0.000517	0.000783	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.000515	0.00266	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000513	0.00265	CbGpPWpGaD
Treprostinil—Decreased appetite—Epirubicin—ovarian cancer	0.000511	0.000773	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—ovarian cancer	0.000508	0.000769	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—ovarian cancer	0.000507	0.000767	CcSEcCtD
Treprostinil—Pain—Epirubicin—ovarian cancer	0.000502	0.000761	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000495	0.00075	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—ovarian cancer	0.000492	0.000744	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—ovarian cancer	0.000488	0.000739	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—ovarian cancer	0.000485	0.000734	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—ovarian cancer	0.000484	0.000733	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00048	0.000727	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—ovarian cancer	0.000479	0.000724	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—ovarian cancer	0.000473	0.000715	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—ovarian cancer	0.000469	0.000709	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—IL6—ovarian cancer	0.000467	0.00242	CbGpPWpGaD
Treprostinil—Pain—Doxorubicin—ovarian cancer	0.000465	0.000704	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—ovarian cancer	0.000465	0.000703	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—ovarian cancer	0.000465	0.000703	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—DOK1—ovarian cancer	0.00046	0.00238	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—YAP1—ovarian cancer	0.000451	0.00233	CbGpPWpGaD
Treprostinil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000448	0.000678	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000445	0.000673	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	0.000437	0.00226	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—ESR1—ovarian cancer	0.000436	0.00226	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP1CC—ovarian cancer	0.000432	0.00224	CbGpPWpGaD
Treprostinil—Body temperature increased—Doxorubicin—ovarian cancer	0.00043	0.000651	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—ovarian cancer	0.00043	0.000651	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—DOK1—ovarian cancer	0.000423	0.00219	CbGpPWpGaD
Treprostinil—Asthenia—Epirubicin—ovarian cancer	0.000422	0.000638	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—ovarian cancer	0.000416	0.000629	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—CAV1—ovarian cancer	0.000414	0.00214	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	0.000414	0.00214	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000408	0.00211	CbGpPWpGaD
Treprostinil—Diarrhoea—Epirubicin—ovarian cancer	0.000402	0.000609	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—PPP1CC—ovarian cancer	0.000398	0.00206	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	0.000394	0.00204	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PGR—ovarian cancer	0.000394	0.00204	CbGpPWpGaD
Treprostinil—Asthenia—Doxorubicin—ovarian cancer	0.00039	0.00059	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—ovarian cancer	0.000389	0.000588	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—ovarian cancer	0.000385	0.000582	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—CAV1—ovarian cancer	0.000381	0.00197	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000381	0.00197	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CG—ovarian cancer	0.000377	0.00195	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000375	0.00194	CbGpPWpGaD
Treprostinil—Vomiting—Epirubicin—ovarian cancer	0.000374	0.000565	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—ovarian cancer	0.000372	0.000563	CcSEcCtD
Treprostinil—Rash—Epirubicin—ovarian cancer	0.00037	0.000561	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—ovarian cancer	0.00037	0.00056	CcSEcCtD
Treprostinil—Headache—Epirubicin—ovarian cancer	0.000368	0.000557	CcSEcCtD
Treprostinil—PPARD—Gene Expression—PARP1—ovarian cancer	0.000366	0.00189	CbGpPWpGaD
Treprostinil—Dizziness—Doxorubicin—ovarian cancer	0.00036	0.000544	CcSEcCtD
Treprostinil—PPARD—Metabolism—YAP1—ovarian cancer	0.00035	0.00181	CbGpPWpGaD
Treprostinil—Nausea—Epirubicin—ovarian cancer	0.000349	0.000528	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—PIK3CG—ovarian cancer	0.000347	0.00179	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000347	0.00179	CbGpPWpGaD
Treprostinil—Vomiting—Doxorubicin—ovarian cancer	0.000346	0.000523	CcSEcCtD
Treprostinil—Rash—Doxorubicin—ovarian cancer	0.000343	0.000519	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—ovarian cancer	0.000342	0.000518	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	0.000342	0.00177	CbGpPWpGaD
Treprostinil—Headache—Doxorubicin—ovarian cancer	0.000341	0.000516	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—PIK3CD—ovarian cancer	0.000331	0.00171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HDAC6—ovarian cancer	0.000328	0.0017	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000323	0.00167	CbGpPWpGaD
Treprostinil—Nausea—Doxorubicin—ovarian cancer	0.000323	0.000489	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCL8—ovarian cancer	0.00031	0.00161	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000306	0.00158	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CD—ovarian cancer	0.000305	0.00158	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000305	0.00158	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000302	0.00156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HDAC6—ovarian cancer	0.000302	0.00156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000297	0.00154	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPP2R1A—ovarian cancer	0.000297	0.00154	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—YAP1—ovarian cancer	0.00029	0.0015	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CB—ovarian cancer	0.000289	0.00149	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—ovarian cancer	0.000286	0.00148	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—FASN—ovarian cancer	0.000286	0.00148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—XIAP—ovarian cancer	0.000284	0.00147	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC5A5—ovarian cancer	0.000281	0.00145	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	0.000279	0.00144	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SMARCA4—ovarian cancer	0.000277	0.00143	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A1—ovarian cancer	0.000271	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EREG—ovarian cancer	0.00027	0.0014	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—YAP1—ovarian cancer	0.000267	0.00138	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CB—ovarian cancer	0.000266	0.00138	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000266	0.00137	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—ovarian cancer	0.000265	0.00137	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—XIAP—ovarian cancer	0.000261	0.00135	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP1B1—ovarian cancer	0.00026	0.00135	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SMARCA4—ovarian cancer	0.000255	0.00132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PGR—ovarian cancer	0.000253	0.00131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EREG—ovarian cancer	0.000249	0.00129	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—ovarian cancer	0.000244	0.00126	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000238	0.00123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000236	0.00122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PARP1—ovarian cancer	0.000235	0.00122	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PGR—ovarian cancer	0.000233	0.00121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPP2R1A—ovarian cancer	0.000231	0.00119	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.00023	0.00119	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—ovarian cancer	0.000227	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—ovarian cancer	0.000225	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6ST—ovarian cancer	0.000225	0.00116	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NRAS—ovarian cancer	0.000223	0.00115	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000219	0.00113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PARP1—ovarian cancer	0.000217	0.00112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CG—ovarian cancer	0.000216	0.00112	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—ovarian cancer	0.000214	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK3—ovarian cancer	0.000213	0.0011	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TYMS—ovarian cancer	0.00021	0.00109	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR1—ovarian cancer	0.00021	0.00109	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000209	0.00108	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—ovarian cancer	0.000207	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6ST—ovarian cancer	0.000207	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—ovarian cancer	0.000205	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK1—ovarian cancer	0.000203	0.00105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—ovarian cancer	0.000199	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—ovarian cancer	0.000196	0.00102	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000193	0.000997	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—ovarian cancer	0.000192	0.000992	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP2R1A—ovarian cancer	0.000191	0.000988	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CD—ovarian cancer	0.00019	0.000984	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK1—ovarian cancer	0.000187	0.000966	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NME2—ovarian cancer	0.000187	0.000965	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000183	0.000944	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—ovarian cancer	0.000176	0.000913	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—ovarian cancer	0.000176	0.000911	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP2R1A—ovarian cancer	0.000176	0.000909	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—ovarian cancer	0.000175	0.000908	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—ovarian cancer	0.000175	0.000905	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—ovarian cancer	0.00017	0.000881	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAV1—ovarian cancer	0.00017	0.000877	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000168	0.000869	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—ovarian cancer	0.000168	0.000867	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—ovarian cancer	0.000166	0.000858	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—ovarian cancer	0.000163	0.000843	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—ovarian cancer	0.000162	0.000838	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000162	0.000838	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—ovarian cancer	0.000161	0.000835	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—ovarian cancer	0.000159	0.000824	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000158	0.000818	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—ovarian cancer	0.000157	0.000811	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—ovarian cancer	0.000154	0.000799	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—ovarian cancer	0.000154	0.000798	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—ovarian cancer	0.000153	0.000789	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—ovarian cancer	0.000152	0.000788	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—ovarian cancer	0.000152	0.000785	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—ovarian cancer	0.00015	0.000776	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—ovarian cancer	0.000147	0.000758	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—ovarian cancer	0.000144	0.000744	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—ovarian cancer	0.00014	0.000726	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—ovarian cancer	0.00014	0.000725	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—ovarian cancer	0.00014	0.000722	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—ovarian cancer	0.000136	0.000702	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—ovarian cancer	0.000135	0.000699	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6ST—ovarian cancer	0.000133	0.000688	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—ovarian cancer	0.000132	0.000685	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—ovarian cancer	0.000129	0.000668	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000129	0.000667	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APC—ovarian cancer	0.000128	0.000661	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—ovarian cancer	0.000128	0.000661	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—ovarian cancer	0.000128	0.000661	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—ovarian cancer	0.000124	0.000644	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6ST—ovarian cancer	0.000122	0.000633	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—ovarian cancer	0.000122	0.000633	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYTB—ovarian cancer	0.00012	0.000622	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—ovarian cancer	0.000118	0.000612	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APC—ovarian cancer	0.000118	0.000608	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—ovarian cancer	0.000118	0.000608	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—ovarian cancer	0.000118	0.000608	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000117	0.000608	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—ovarian cancer	0.000116	0.000602	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—ovarian cancer	0.000116	0.000602	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—ovarian cancer	0.000113	0.000583	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—ovarian cancer	0.000112	0.000581	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—ovarian cancer	0.000112	0.000581	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000111	0.000576	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—ovarian cancer	0.00011	0.000569	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—ovarian cancer	0.000109	0.000565	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—ovarian cancer	0.000107	0.000554	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—ovarian cancer	0.000107	0.000554	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BRIP1—ovarian cancer	0.000105	0.000543	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	0.000105	0.000543	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—ovarian cancer	0.000103	0.000535	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000102	0.00053	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—ovarian cancer	0.000102	0.000529	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—ovarian cancer	0.000101	0.000524	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—ovarian cancer	0.000101	0.000523	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB2—ovarian cancer	9.92e-05	0.000513	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—ovarian cancer	9.79e-05	0.000507	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—ovarian cancer	9.79e-05	0.000507	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—ovarian cancer	9.41e-05	0.000487	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—ovarian cancer	9.35e-05	0.000484	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—ovarian cancer	9.3e-05	0.000481	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—ovarian cancer	9.19e-05	0.000475	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB2—ovarian cancer	9.13e-05	0.000472	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—ovarian cancer	9.09e-05	0.00047	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—ovarian cancer	9.01e-05	0.000466	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—ovarian cancer	9.01e-05	0.000466	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—ovarian cancer	9.01e-05	0.000466	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—ovarian cancer	8.99e-05	0.000465	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—ovarian cancer	8.95e-05	0.000463	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—ovarian cancer	8.77e-05	0.000454	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—ovarian cancer	8.68e-05	0.000449	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—ovarian cancer	8.66e-05	0.000448	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—ovarian cancer	8.6e-05	0.000445	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—ovarian cancer	8.51e-05	0.00044	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—ovarian cancer	8.46e-05	0.000438	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—ovarian cancer	8.46e-05	0.000438	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—ovarian cancer	8.37e-05	0.000433	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—ovarian cancer	8.29e-05	0.000429	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—ovarian cancer	8.28e-05	0.000428	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—ovarian cancer	8.26e-05	0.000427	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—ovarian cancer	8.24e-05	0.000426	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—ovarian cancer	8.07e-05	0.000417	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—ovarian cancer	7.99e-05	0.000413	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—ovarian cancer	7.83e-05	0.000405	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—ovarian cancer	7.79e-05	0.000403	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.66e-05	0.000396	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—ovarian cancer	7.64e-05	0.000395	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—ovarian cancer	7.6e-05	0.000393	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—ovarian cancer	7.58e-05	0.000392	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—ovarian cancer	7.57e-05	0.000392	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—ovarian cancer	7.55e-05	0.000391	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—ovarian cancer	7.23e-05	0.000374	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—ovarian cancer	7.21e-05	0.000373	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—YAP1—ovarian cancer	7.05e-05	0.000365	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—ovarian cancer	7.03e-05	0.000364	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—ovarian cancer	7.03e-05	0.000364	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.97e-05	0.000361	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—ovarian cancer	6.96e-05	0.00036	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—ovarian cancer	6.95e-05	0.000359	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—ovarian cancer	6.88e-05	0.000356	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—ovarian cancer	6.88e-05	0.000356	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—ovarian cancer	6.65e-05	0.000344	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—ovarian cancer	6.5e-05	0.000336	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—ovarian cancer	6.47e-05	0.000335	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—ovarian cancer	6.33e-05	0.000328	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—ovarian cancer	6.33e-05	0.000327	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.13e-05	0.000317	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—ovarian cancer	5.98e-05	0.000309	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—ovarian cancer	5.97e-05	0.000309	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—ovarian cancer	5.89e-05	0.000305	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—ovarian cancer	5.78e-05	0.000299	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FASN—ovarian cancer	5.74e-05	0.000297	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.65e-05	0.000292	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—ovarian cancer	5.52e-05	0.000286	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—ovarian cancer	5.49e-05	0.000284	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.46e-05	0.000282	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.34e-05	0.000276	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—ovarian cancer	5.31e-05	0.000275	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—ovarian cancer	5.29e-05	0.000273	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.23e-05	0.000271	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—ovarian cancer	5.08e-05	0.000263	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—ovarian cancer	4.88e-05	0.000252	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—ovarian cancer	4.86e-05	0.000252	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.64e-05	0.00024	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.62e-05	0.000239	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—ovarian cancer	4.49e-05	0.000232	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.31e-05	0.000223	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TYMS—ovarian cancer	4.23e-05	0.000219	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—ovarian cancer	3.41e-05	0.000176	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.26e-05	0.000169	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.11e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.73e-05	0.000141	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.38e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—ovarian cancer	2.06e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.45e-05	7.5e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—ovarian cancer	1.18e-05	6.13e-05	CbGpPWpGaD
Treprostinil—Nadolol—ABCB1—ovarian cancer	9.58e-06	1	CrCbGaD
